Dr Jesus Fabregas speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium about his highlights in gastrointestinal tumour research from this year’s meeting.

He explains the rationale and results from the ESOPEC, Checkmate-8HW and PASS-01 trials  - highlighting them as the most promising from this meeting. 

Dr Fabregas believes that we need to build on these trials and  gain for information on these treatment combinations before deciding what to do with patients in the clinic.